Danilo Neglia (@daniloneglia) 's Twitter Profile
Danilo Neglia

@daniloneglia

Cardiologist with an interest in research and...some optimism about the future.

ID: 1252308924176441344

calendar_today20-04-2020 18:51:48

4 Tweet

32 Followers

18 Following

Alessia Gimelli (@alessia_gimelli) 's Twitter Profile Photo
Alessia Gimelli
@alessia_gimelli

4 years ago

Don't miss the Late-Breaking Science Session on August 29, start time 10:30. The EURECA results (Use of imaging in CCS) will be presented. Stay tuned Danilo Neglia Leslee Shaw Victoria Delgado Denisa Muraru Cosyns Bernard Bogdan A. Popescu Gianluca Pontone Pál Maurovich-Horvat @MarcDweck

Don't miss the Late-Breaking Science Session on August 29, start time 10:30. The EURECA results (Use of imaging in CCS) will be presented. Stay tuned <a href="/DaniloNeglia/">Danilo Neglia</a> <a href="/lesleejshaw/">Leslee Shaw</a> <a href="/VDelgadoGarcia/">Victoria Delgado</a> <a href="/denisamuraru/">Denisa Muraru</a> <a href="/Cosyns/">Cosyns Bernard</a> <a href="/bogdan_popescu1/">Bogdan A. Popescu</a> <a href="/gpontone1/">Gianluca Pontone</a> <a href="/PalMaurovich/">Pál Maurovich-Horvat</a> @MarcDweck
Stephan Achenbach (@steph_achenbach) 's Twitter Profile Photo
Stephan Achenbach
@steph_achenbach

4 years ago

Emperor-Reduced at #ESCCongress, significant reduction of hospitalizations for HF in pts with HF but no reduced LVEF. NNT only 31 & RR reduction 21% for combined endpoint of HF hospitalization plus CV death. Beneficial effects also re: decline in renal fct. Body weight ⬇️ 1.3%!

Emperor-Reduced at #ESCCongress, significant reduction of hospitalizations for HF in pts with HF but no reduced LVEF. NNT only 31 &amp; RR reduction 21% for combined endpoint of HF hospitalization plus CV death. Beneficial effects also re: decline in renal fct. Body weight ⬇️ 1.3%!
European Society of Cardiology (@escardio) 's Twitter Profile Photo
European Society of Cardiology
@escardio

4 years ago

#EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes #ESCCongress

#EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes #ESCCongress
Vass Vassiliou (@vass_vassiliou) 's Twitter Profile Photo
Vass Vassiliou
@vass_vassiliou

4 years ago

#ESCCongress #ESCGuidelines This is a Long thread on Heart Failure Guidelines published European Society of Cardiology #EHJ academic.oup.com/eurheartj/adva… LONG BUT EDUCATIONAL! Focus on CHRONIC HF #epeeps #CardioEd Alexandra Frogoudaki Mamas A. Mamas Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Dr. Purvi Parwani Gerasimos Filippatos Ekaterini Lambrinou💙 Hany Ragy …/2

#ESCCongress #ESCGuidelines This is a Long thread on Heart Failure Guidelines published <a href="/escardio/">European Society of Cardiology</a> #EHJ academic.oup.com/eurheartj/adva… LONG BUT EDUCATIONAL! Focus on CHRONIC HF #epeeps #CardioEd <a href="/AlexFrogoudaki/">Alexandra Frogoudaki</a> <a href="/mmamas1973/">Mamas A. Mamas</a> <a href="/DrMarthaGulati/">Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦</a> <a href="/purviparwani/">Dr. Purvi Parwani</a> <a href="/Filippatos/">Gerasimos Filippatos</a> <a href="/EkateriniL/">Ekaterini Lambrinou💙</a> <a href="/Hragy/">Hany Ragy</a> …/2